Novartis AG Common Stock · Operating Cash Flow (Statement)

Latest reported$18.39Bperiod endingJun 30, 2026

NVS Cash from Operations ($4.28B → $18.39B)

Annual operating cash flow (statement)

High-resolution chart · PNG

NVS operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	19,242,034,000
Dec 31, 2024	17,619,000,000
Dec 31, 2023	14,458,000,000
Dec 31, 2022	14,236,000,000
Dec 31, 2021	15,071,000,000
Dec 31, 2020	13,650,000,000
Dec 31, 2019	13,625,000,000
Dec 31, 2018	14,272,000,000
Dec 31, 2017	12,621,000,000
Dec 31, 2016	11,475,000,000
Dec 31, 2015	11,897,000,000
Dec 31, 2014	13,897,000,000
Dec 31, 2013	13,174,000,000
Dec 31, 2012	14,194,000,000
Dec 31, 2011	14,309,000,000
Dec 31, 2010	14,067,000,000
Dec 31, 2009	12,191,000,000
Dec 31, 2008	9,769,000,000
Dec 31, 2007	9,210,000,000
Dec 31, 2006	8,710,000,000
Dec 31, 2005	8,080,000,000
Dec 31, 2004	6,725,000,000
Dec 31, 2003	6,652,000,000
Dec 31, 2002	5,830,000,000
Dec 31, 2001	4,431,000,000
Dec 31, 2000	4,641,000,000
Dec 31, 1999	4,335,000,000
Dec 31, 1998	4,277,616,279